{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:53:59Z","timestamp":1791424439915,"version":"4.3.3"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172854"],"award-info":[{"award-number":["81172854"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81240015"],"award-info":[{"award-number":["81240015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.intimp.2015.12.023","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T01:45:18Z","timestamp":1451353518000},"page":"158-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Potent antigen-specific immune response induced by infusion of spleen cells coupled with succinimidyl-4-(N-maleimidomethyl cyclohexane)-1-carboxylate (SMCC) conjugated antigens"],"prefix":"10.1016","volume":"31","author":[{"given":"Yixian","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2036-1837","authenticated-orcid":false,"given":"Tyler","family":"Werbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suigui","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Clare-Salzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Qing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2015.12.023_bb0005","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2015.12.023_bb0010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMra1204186","article-title":"Designing tomorrow's vaccines","volume":"368","author":"Nabel","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2015.12.023_bb0015","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrd3402","article-title":"Immunomodulatory therapy to preserve pancreatic beta-cell function in type 1 diabetes","volume":"10","author":"Waldron-Lynch","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2015.12.023_bb0020","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00262-012-1354-x","article-title":"Bioinformatics for cancer immunology and immunotherapy","volume":"61","author":"Charoentong","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2015.12.023_bb0025","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2337\/dc12-0063","article-title":"Improvement in outcomes of clinical islet transplantation: 1999\u20132010","volume":"35","author":"Barton","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2015.12.023_bb0030","article-title":"Dendritic cell-based vaccine research against cancer","volume":"1-20","author":"Mody","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.intimp.2015.12.023_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2013.07.004","article-title":"Dendritic-cell-based therapeutic cancer vaccines","volume":"39","author":"Palucka","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2015.12.023_bb0040","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature14320","article-title":"Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients","volume":"519","author":"Mitchell","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2015.12.023_bb0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nature14211","article-title":"Cancer immunotherapy: dendritic-cell vaccines on the move","volume":"519","author":"Sabado","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2015.12.023_bb0050","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.4049\/jimmunol.155.12.5861","article-title":"Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism","volume":"155","author":"Vandenbark","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2015.12.023_bb0055","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaut.2006.12.002","article-title":"Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities","volume":"27","author":"Smith","year":"2006","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2015.12.023_bb0060","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1084\/jem.20061577","article-title":"Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway","volume":"203","author":"Fife","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2015.12.023_bb0065","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","article-title":"Click chemistry: diverse chemical function from a few good reactions","volume":"40","author":"Kolb","year":"2001","journal-title":"Angewandte Chemie."},{"key":"10.1016\/j.intimp.2015.12.023_bb0070","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1021\/jo9607424","article-title":"1,3-dipolar activity in cycloadditions of an aliphatic sulfine(,)(1)","volume":"61","author":"Huisgen","year":"1996","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.intimp.2015.12.023_bb0075","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1073\/pnas.2628032100","article-title":"Lymphocyte surface thiol levels","volume":"100","author":"Sahaf","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2015.12.023_bb0080","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nm.2198","article-title":"Therapeutic cell engineering with surface-conjugated synthetic nanoparticles","volume":"16","author":"Stephan","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2015.12.023_bb0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0022-1759(84)90290-4","article-title":"Rapid covalent coupling of proteins to cell surfaces: immunological characterization of viable protein-cell conjugates","volume":"74","author":"Christiaansen","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.intimp.2015.12.023_bb0090","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/nprot.2007.296","article-title":"Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester","volume":"2","author":"Quah","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.intimp.2015.12.023_bb0095","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/jlb.60.5.611","article-title":"Surface thiols of human lymphocytes and their changes after in vitro and in vivo activation","volume":"60","author":"Lawrence","year":"1996","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2015.12.023_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081134","article-title":"Increased cell surface free thiols identify effector CD8+ T cells undergoing T cell receptor stimulation","volume":"8","author":"Pellom","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2015.12.023_bb0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00986726","article-title":"A practical approach to crosslinking","volume":"17","author":"Mattson","year":"1993","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.intimp.2015.12.023_bb0110","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40265-013-0050-2","article-title":"Trastuzumab emtansine: first global approval","volume":"73","author":"Ballantyne","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2015.12.023_bb0115","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/00000542-200612000-00015","article-title":"A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified hemoglobin (hemospan) in patients undergoing major orthopedic surgery","volume":"105","author":"Olofsson","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.intimp.2015.12.023_bb0120","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1073\/pnas.051626298","article-title":"Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial","volume":"98","author":"Gilewski","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2015.12.023_bb0125","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1084\/jem.190.10.1439","article-title":"Instruction for cytokine expression in T helper lymphocytes in relation to proliferation and cell cycle progression","volume":"190","author":"Richter","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2015.12.023_bb0130","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.4049\/jimmunol.174.8.4639","article-title":"Signals from CD28 induce stable epigenetic modification of the IL-2 promoter","volume":"174","author":"Thomas","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2015.12.023_bb0135","doi-asserted-by":"crossref","first-page":"18707","DOI":"10.1074\/jbc.M113.545210","article-title":"Histone modifications are associated with Delta9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses","volume":"289","author":"Yang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2015.12.023_bb9000","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/129682","article-title":"Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35\u201355-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice","volume":"2015","author":"Zhang","year":"2015","journal-title":"J. Immunol. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915302289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915302289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T09:06:55Z","timestamp":1692176815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576915302289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":28,"alternative-id":["S1567576915302289"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2015.12.023","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent antigen-specific immune response induced by infusion of spleen cells coupled with succinimidyl-4-(N-maleimidomethyl cyclohexane)-1-carboxylate (SMCC) conjugated antigens","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2015.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}